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AbstrACt
Objective To determine research priorities in fragility 
fractures of the lower limb and pelvis which represent 
the shared priorities of patients, their friends and 
families, carers and healthcare professionals.
Design/setting A national (UK) research priority setting 
partnership.
Participants Patients over 60 years of age who have 
experienced a fragility fracture of the lower limb or pelvis; 
carers involved in their care (both in and out of hospital); 
family and friends of patients; healthcare professionals 
involved in the treatment of these patients including but 
not limited to surgeons, anaesthetists, paramedics, nurses, 
general practitioners, physicians, physiotherapists and 
occupational therapists.
Methods Using a multiphase methodology in 
partnership with the James Lind Alliance over 
18 months (August 2016–January 2018), a national 
scoping survey asked respondents to submit their 
research uncertainties. These were amalgamated 
into a smaller number of research questions. The 
existing evidence was searched to ensure that the 
questions had not been answered. A second national 
survey asked respondents to prioritise the research 
questions. A final shortlist of 25 questions was taken to 
a multistakeholder workshop where a consensus was 
reached on the top 10 priorities.
results There were 963 original uncertainties submitted 
by 365 respondents to the first survey. These original 
uncertainties were refined into 88 research questions of 
which 76 were judged to be true uncertainties following a 
review of the research evidence. Healthcare professionals 
and other stakeholders (patients, carers, friends and 
families) were represented equally in the responses. 
The top 10 represent uncertainties in rehabilitation, pain 
management, anaesthesia and surgery.
Conclusions We report the top 10 UK research 
priorities in patients with fragility fractures of the lower 
limb and pelvis. The priorities highlight uncertainties 
in rehabilitation, postoperative physiotherapy, pain, 
weight-bearing, infection and thromboprophylaxis. The 
challenge now is to refine and deliver answers to these 
research priorities.
IntrODuCtIOn 
An estimated nine million fragility fractures 
occurred worldwide in the year 2000, with 
50 million people suffering from the sequelae 
of these fractures.1 Hip fractures alone are 
expected to rise from 1.31 million in 1990 to 
an estimated 6.26 million per year globally by 
2050.2 In the UK, over 300 000 patients present 
to hospital with fragility fractures,3 and the asso-
ciated treatment costs are around 2% of the 
total healthcare burden in the UK—approxi-
mately £3 billion per year.4 
Adults with fragility fractures of the lower 
limb or pelvis usually require treatment in 
hospital and often have other medical comor-
bidities, along with complex health and social 
care needs requiring intervention from a 
number of healthcare professionals and carers.
There is evidence of a mismatch between the 
research priorities of patients and healthcare 
professionals and the research which is actually 
undertaken and delivered.5–7 This situation is 
changing. Patient and public involvement (PPI) 
in research has flourished in the UK, driven 
by the National Institute of Health Research 
(NIHR) such that PPI involvement is now a 
strengths and limitations of this study
 ► Use of established and transparent James Lind 
Alliance methodology.
 ► Survey responses from all over the UK with a 
50:50 split between healthcare professionals and 
non-healthcare professionals (patients, carers, fam-
ily and friends).
 ► While the research priorities are now reported, it is 
up to the research community and research funding 
organisations to refine and deliver the answers to 
these questions.
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key part of the design, conduct and delivery of research in 
health and social care.8
The James Lind Alliance (JLA) is a non-profit organi-
sation hosted by the NIHR with the aim of raising aware-
ness of research which is directly relevant and of potential 
benefit to patients and treating clinicians. The guiding 
principle is to bring together patients, carers and clini-
cians to identify and agree on which research uncertain-
ties are most important. To date, there have been over 50 
priority setting partnerships across a range of disciplines 
with over 100 research topics addressed as a direct result 
of the JLA priority setting partnerships.9 10
The aim of this work is to establish the research priori-
ties for adults with fragility fractures of the lower limb and 
pelvis which represent the shared interests and priorities 
of patients, their families and friends, carers and health-
care professionals.
MethODs
The ‘Broken Bones in Older People’ priority setting 
partnership (PSP) took place over an 18-month period 
between August 2016 and January 2018. An overview of 
the methodology is shown in figure 1.
steering group and partner organisations
The clinical lead (MC) initiated the PSP and guided the 
appointment of a steering group to oversee and contribute 
to the process. The steering group consisted of patient 
representatives, healthcare professionals and carers with 
established links to relevant partner organisations (see 
online supplementary appendix 1) to ensure that a range 
of stakeholder groups were represented. Steering group 
members did so on a voluntary basis and were expected to 
commit to the whole process where possible. A JLA adviser 
(CW) supported and guided the PSP as a neutral facilitator 
to ensure that it was undertaken in a fair and transparent 
way, encouraging equal contributions from patients, carers 
and healthcare professionals. This is an important aspect 
of the JLA process and ensures that all voices are heard 
and respected throughout the process. An information 
specialist (MF) managed the data and performed the 
analysis. This was overseen and advised on by the steering 
group.
scope
All research uncertainties related to fragility fractures of 
the lower limbs and pelvis for patients over 60 years of 
age were considered in scope. All stages of the patient 
pathway were eligible including the immediate care of 
fragility fractures by the emergency services, acute in-hos-
pital care and out-of-hospital care. Primary prevention 
strategies for fragility fractures were excluded. The deci-
sions about whether submissions were in or out-of-scope 
were made by the information specialist and subsequently 
verified by the steering group.
scoping survey and identification of themes
A national scoping survey asked respondents to submit 
their research uncertainties and provide some optional 
basic demographic information (gender, first three letters 
of their postcode and to identify themselves as either a 
carer, patient, family/friend of someone over 60 years of 
age with a fragility fracture or a healthcare professional). 
The survey was circulated via the steering group and their 
partner organisations as an open invitation. The survey 
was available in both paper and online formats (Bristol 
online survey tool).11 A pilot phase was undertaken to 
ensure that the survey was clearly written, understandable 
to all groups and easy to complete. In addition to submis-
sions from survey respondents, we included research 
uncertainties highlighted in relevant national guidelines 
published by the National Institute for Health and Care 
Excellence.12 13
All original submissions were analysed using techniques 
common to qualitative thematic analysis to define themes 
and subthemes. The process included initial data immer-
sion (reading and re-reading the submissions), coding 
of common ideas/themes, identification and naming of 
themes and subthemes, and a final review to refine the 
overarching themes. The thematic analysis was under-
taken by the information specialist and decisions verified 
by the steering group. In order to do this, the steering 
group were given the opportunity to review all of the orig-
inal submissions under each theme/subtheme. These 
were then referred to during the verification process.
Indicative questions and evidence search
The overarching themes and subthemes from the 
thematic analysis were used to generate a smaller number 
of representative research questions, so-called ‘indicative 
questions’. These were derived from the original submis-
sions and were designed to summarise the submissions 
within each subtheme/theme. The information specialist 
undertook this process. The indicative questions were then 
reviewed by the steering group along with a selection of 
the original uncertainties to ensure that they were a true 
representation, and to ensure that the language used was 
understandable to all stakeholder groups. For each indic-
ative question, a review of the current research evidence 
was undertaken to ensure that the proposed indicative 
questions were ‘true uncertainties’ and had not already 
been answered by research. MF searched PubMed, the 
grey literature (www. opengrey. eu), the Cochrane Central 
Register of Controlled Trials (www. cochranelibrary. 
com/ about/ central- landing- page. hml), the WHO Inter-
national Clinical Trials Registry Platform Search Portal 
(http://www. who. int/ ictrp/ en), Current Controlled 
trials (http://www. controlledtrials. com/ isrctn/), the US 
National Institute of Health Trials Registry (https:// clin-
icaltrials. gov) and published UK national guidelines.12 13 
Indicative questions were excluded if the steering group 
agreed that high-quality evidence was found (eg, large 
clinical trials either published or in-progress, published 
meta-analyses or published national evidence-based 
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guidelines). The remaining indicative questions went 
through to interim prioritisation.
Interim prioritisation survey
A second national survey asked respondents to state the 
importance of each indicative question on a five-level 
Likert scale (1 not important, 2 low importance, 3 no 
opinion, 4 high importance, 5 extremely important). 
The survey was available in paper and online formats and 
went through a pilot phase prior to launch. The second 
survey was again circulated as an open invitation and 
not restricted to respondents from the first survey. All 
indicative questions were ranked (interim prioritisation) 
by calculating a mean score per question based on the 
number of responses at each of the five response levels. 
The results were reviewed by the steering group who 
decided to take the top 25 to the final workshop.
Figure 1 Flow chart of priority setting partnership process. NICE, National Institute for Health and Care Excellence.
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Final workshop
This was a 1-day multistakeholder workshop involving 
patients, carers and healthcare professionals. Participants 
worked in small groups to independently rank the top 
25 indicative questions from the interim prioritisation 
process. The combined results of small group discussions 
were presented to the whole group. These were consid-
ered before a further round of small group discussions. 
Finally, the whole group came back together again to 
establish a consensus on the top 10 research priorities for 
fragility fractures of the lower limb and pelvis. The role of 
the steering group at this stage was to ensure that patients 
and carers were well supported with information and with 
practical support on the day. As places in the final work-
shop were limited, the majority of the steering group did 
not participate in the final workshop.
Patient and public involvement
Patient and carer representatives were actively involved 
throughout the process; from the initial stages of planning 
and overseeing the study as part of the steering group, to 
participation in the final workshop to ensure that the patient 
and carer ‘voice’ was represented in the final prioritisation. 
The steering group made particular efforts to approach a 
diverse range of patient and carer groups across a number 
of settings to encourage responses to the surveys. The 
dissemination strategy of this work includes a plain English 
summary alongside the scientific publication which will be 
circulated to the partner organisations and PPI groups.
results
Nine hundred and sixty-three research uncertainties were 
submitted by 365 respondents to the first survey. After 
removal of ‘out-of-scope’ uncertainties, there were 810 
remaining. Respondents were located throughout the 
UK. Fifty-one per cent of respondents identified them-
selves as healthcare professionals and 49% non-health-
care professionals (23% family and friends, 16% patients, 
10% carers).
Eleven themes were identified: pain, nutrition, surgery, 
medications and devices, anaesthesia, rehabilitation, 
falls, anxiety and depression, diagnosis, information and 
service delivery. From these themes, 88 indicative ques-
tions were formulated to represent the original uncertain-
ties. Twelve indicative questions were excluded following 
a search of the research evidence, leaving 76 indicative 
questions for interim prioritisation.
The interim prioritisation survey received 209 
responses from different regions of the UK, of which 
47% identified themselves as healthcare professionals 
and 53% non-healthcare professionals (15% family and 
friends, 28% patients, 10% carers). Each question was 
scored based on the responses to interim prioritisation 
and ranked from positions 1 to 76. The ranking was 
reviewed by the steering group, and the top 25 questions 
were taken to the final prioritisation workshop where a 
consensus was reached on the top 10 research priorities 
(see figure 2 for priorities 1–10 and online supplemen-
tary appendix 2 for priorities 11–25). You can see the 
full list of original uncertainties and indicative research 
questions at the following websites: www. jla. nihr. ac. uk/ 
priority- setting- partnerships/ broken- bones- in- older- 
people/ www. ndorms. ox. ac. uk/ research- groups/ oxford- 
trauma/ broken- bones- in- older- people.
DIsCussIOn
We have reported the results of a UK PSP with the JLA 
and identified the top 10 research priorities in patients 
with fragility fractures of the lower limb and pelvis. 
These research priorities represent the shared interests 
of the multiple stakeholders affected by fragility frac-
tures: patients, family and friends, carers and healthcare 
professionals. The top 10 priorities emphasise the lack of 
evidence to guide ‘rehabilitation’ following fragility frac-
ture and highlight a number of unanswered questions in 
postoperative physiotherapy, weight-bearing and rehabil-
itation pathways for patients with cognitive impairment.
This study has a number of strengths. This is the first study 
to report national research priorities in fragility fractures of 
the lower limb and pelvis in partnership with the JLA. These 
priorities compliment research priorities highlighted by 
national guidelines in this area which also highlight research 
uncertainties in rehabilitation and physiotherapy.12Patient 
and carers were actively involved at all stages of the process 
to ensure that the patient voice was heard and remained 
at the centre of our efforts. We used the established and 
transparent JLA methodology to conduct this PSP. All the 
original research submissions and the indicative questions 
(76 in total) are available on the JLA website.9 The number 
of survey responses were comparable with other JLA PSPs,14 
and we achieved a 50:50 balance between responses from 
healthcare professionals and non-healthcare professionals. 
Responses have been submitted from all over the UK, and 
we are therefore confident that this work represents a 
national viewpoint.
Fragility fractures affect frail older people dispropor-
tionately. Considerable efforts were required to ensure 
that all patient groups were able to access and respond to 
our national surveys. These strategies included accessing 
clinical environments (eg, General Practice surgeries, 
hospital outpatient clinics) with paper surveys and sending 
our online survey link via the mailing lists of national 
organisations such as the National Osteoporosis Society 
to ensure as widespread inclusion of patient groups as 
possible. However, despite these efforts, it is possible 
that the research priorities reported still under-represent 
the frailest group which includes those with permanent 
cognitive impairment for whom responding to a survey 
may not be possible. However, we are encouraged to see 
a research uncertainty in the top 10 specifically directed 
towards identifying the key components of a rehabilita-
tion pathway for those with chronic cognitive impairment.
We found that research questions which were 
very specific—which identified the intervention and 
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comparator within the question—tended to attract a 
lower ranking than more general questions asking a 
broader less well-defined research question. For example, 
questions asking ‘What is the best physiotherapy?’ were 
found to attract more votes than more specific questions 
comparing two specific interventions (eg, ‘Which is better, 
tai chi or standard physiotherapy?’). This may reflect an 
opinion by survey respondents that broader questions 
may have wider impact and cover multiple interventions. 
Nevertheless, we felt it was important to strike a balance 
between more general questions and questions about 
specific interventions such that the spectrum of the orig-
inal submissions was accurately reflected. Future prioriti-
sation partnerships will need to consider this aspect of the 
process and decide on the right balance between inclu-
sion of specific versus general indicative questions.
This work has highlighted the top research questions 
in lower limb and pelvic fragility fracture research. It is 
now up to the research community and research funders 
to refine and deliver the answers to these questions. We 
hope this work will shape the research landscape in this 
area and help to deliver meaningful advances in the qual-
ity-of-life and care of patients.
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Figure 2 The top 10 UK research priorities in fragility fractures of the lower limb and pelvis.
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